Article Versions Notes

Gadour E, Miutescu B, Bashir H, Ali A, Alanzi S, Al-Shahrani AA, Almuhaidb A, Mohamed S, Abaalkhail F, Kuriry H, et al. Efficacy and Safety of Novel Oral Anti-Cholestatic Agents for Primary Biliary Cholangitis: Meta-Analyses and Systematic Review. Pharmaceuticals. 2025; 18(5):697. https://doi.org/10.3390/ph18050697

Gadour, Eyad, Bogdan Miutescu, Hiba Bashir, Abubaker Ali, Salem Alanzi, Abdullah A. Al-Shahrani, Aymen Almuhaidb, Shahed Mohamed, Faisal Abaalkhail, Hadi Kuriry, and et al. 2025. "Efficacy and Safety of Novel Oral Anti-Cholestatic Agents for Primary Biliary Cholangitis: Meta-Analyses and Systematic Review" Pharmaceuticals 18, no. 5: 697. https://doi.org/10.3390/ph18050697

Gadour, E., Miutescu, B., Bashir, H., Ali, A., Alanzi, S., Al-Shahrani, A. A., Almuhaidb, A., Mohamed, S., Abaalkhail, F., Kuriry, H., & AlQahtani, M. S. (2025). Efficacy and Safety of Novel Oral Anti-Cholestatic Agents for Primary Biliary Cholangitis: Meta-Analyses and Systematic Review. Pharmaceuticals, 18(5), 697. https://doi.org/10.3390/ph18050697